A bone graft repairs and rebuilds diseased bone and transplants bone tissues of the hips, knees, spine, and various other bones in the body. Moreover, it repairs bone loss caused by fractures and cancers. The body accepts the newly implanted graft and provides a framework for growth of new living bone. Bone grafts can be obtained either from the patient’s own body, a donor or can be entirely man-made from natural or synthetic materials. Autografts and allograft are the most common types of bone grafts. In allograft, bone is obtained from a deceased donor or a cadaver that is sterilized and stored in the tissue or bone banks. In autografts, bone is obtained from the patient’s own body parts such as ribs, pelvis, wrist, and hips. Furthermore, bone graft substitutes made up of materials such as ceramics and polymers are gaining preference. This is owing to osteoconductive and osteogenerative properties and easy availability of these grafts.

Get the inside scoop of the Sample report @ https://www.coherentmarketinsights.com/insight/request-sample/2644

Market Dynamics

Latin America bone graft and substitutes market is expected to witness significant growth over the forecast period, owing to increasing adoption of new technologies by manufacturers to develop novel bone graft substitutes. For instance, in March 2015, Osiris Therapeutics, Inc., a company based in Columbia, Maryland, introduced BIO4. BIO4 is a viable bone matrix containing endogenous bone forming cells including mesenchymal stem cells, osteoprogenitor cells, osteoblasts, osteoinductive, and angiogenic growth factors. BIO4 has all four characteristics involved in bone repair and regeneration including osteoconductive, osteoinductive, osteogenic, and angiogenic characteristics. It is a safe alternative to bone autograft that minimizes the potential for harvest site co-morbidities.

The Latin America bone graft and substitutes market was valued at US$ 116.8 million in 2018, and is expected to witness a CAGR of 5.6% during the forecast period (2018– 2026).

Latin America Bone Graft and Substitutes Market – Country-Wise Analysis

On the basis of country-wise segmentation, Latin America bone graft and substitutes market is divided into Colombia, Peru, Chile, and the rest of Latin America.

Colombia is projected to witness significant growth in Latin America bone graft and substitute market, owing to growing healthcare sector in the country. According to the World Health Organization (WHO), Colombia has the best and high quality healthcare system among all the Latin American countries. Moreover, WHO has ranked Colombia’s healthcare system at 22nd position out of all 191 countries across the world.

Latin America Bone Graft and Substitutes Market- Competitive Landscape

Key players operating in Latin America bone graft and substitutes market include, RTI Surgical, Inc., NuVasive, Inc., Exactech, Inc., Medtronic Plc., LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, Johnson & Johnson, Orthofix International N.V., Ace Surgical Supply Co., Inc., and Novabone Product, LLC

Detailed Segmentation:

Latin America Bone Graft and Substitutes Market , By Product Type:
• Bone Graft
- Allografts
- Xenografts
• Bone Graft Substitutes
- Ceramics
- Composites
- Polymers
- Bone Morphogenetics Proteins
- Others

Latin America Bone Graft and Substitutes Market , By Application:
• Spinal Fusion
• Dental Bone Grafts
• Craniomaxillofacial
• Joint Reconstruction
• Trauma

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/market-insight/latin-america-bone-graft-and-substitutes-market-2644

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]